DDX41 and Zika virus infectious disease: When evaluating the neutralizing titers against all four DENV serotypes, we observed a boost in neutralization against all serotypes in all three groups, suggesting that a subsequent ZIKV infection impact the levels of heterologous DENV-neutralizing Abs (S6B Fig).